Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications-Reference-Cited by-同舟云学术

Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications

Published:2017-01-30 Issue:2 Volume:47 Page:161-175
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Robinson D.¹^ORCID,Humbert M.²,Buhl R.³,Cruz A. A.⁴,Inoue H.⁵,Korom S.⁶,Hanania N. A.⁷,Nair P.⁸^ORCID

Affiliation:

1. Department of Respiratory Medicine; Severe Asthma Service; UCLH NHS Trust; London UK

2. Service de Pneumologie; Hôpital Bicêtre; Assistance Publique Hôpitaux de Paris; University Paris-Sud; Université Paris-Saclay; INSERM U999; Le Kremlin-Bicêtre France

3. Pulmonary Department; Mainz University Hospital; Mainz Germany

4. ProAR-Center of Excellence in Asthma; Federal University of Bahia School of Medicine; Salvador Brazil

5. Department of Pulmonary Medicine; Graduate School of Medical and Dental Sciences; Kagoshima University; Kagoshima Japan

6. F. Hoffmann-La Roche Ltd; Basel Switzerland

7. Section of Pulmonary and Critical Care Medicine; Baylor College of Medicine; Houston TX USA

8. Division of Respirology; Department of Medicine; McMaster University; Hamilton ON Canada

Funder

AstraZeneca

Chiesi Farmaceutici

Roche

Teva Pharmaceutical Industries

Boehringer Ingelheim

GlaxoSmithKline

Novartis

Sanofi-Aventis

Merck Sharp and Dohme

Mylan

Astellas Pharma US

ChugaiPharm

Pfizer

Teijin-Pharma and Torii

Sanofi

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.12880/fullpdf

Reference177 articles.

1. Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention - updated 2016 2016 http://ginasthma.org/gina-reports/

2. A summary of the new GINA strategy: a roadmap to asthma control;Reddel;Eur Respir J,2015

3. Asthma: defining of the persistent adult phenotypes;Wenzel;Lancet,2006

4. Asthma phenotypes and endotypes: an evolving paradigm for classification;Corren;Discov Med,2013

5. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome;Lotvall;J Allergy Clin Immunol,2011

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Study on Natural Products and their Bioactive Constituents to Cure Respiratory Diseases;The Natural Products Journal;2024-03

2. Asthma May Not be a Potential Risk Factor for Severe COVID-19 Illness: A Scoping Review;Environmental Health Insights;2024-01

3. Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma;Thorax;2023-12-30

4. Asthma control and sputum eosinophils in adult patients: a cross-sectional study in southern Brazil;Scientific Reports;2023-12-05

5. Itaconate as a key regulator of respiratory disease;Clinical and Experimental Immunology;2023-11-29